WINT

WINT

USD

Windtree Therapeutics Inc. Common Stock

$1.210+0.050 (4.310%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.160

Máximo

$1.240

Mínimo

$1.150

Volumen

0.00M

Fundamentos de la Empresa

Capitalización de Mercado

4.3M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

2.85M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.01Actual $1.210Máximo $737.5

Noticias Relacionadas

PR Newswire

Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics

Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced that it has entered into a License and Supply Agreement (L&S...

Ver más
Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics
GlobeNewswire

Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product

WARRINGTON, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating biotech and advancing

Ver más
Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.